EU drug regulator EMA expects Johnson & Johnson (JNJ) to file for approval of its COVID-19 vaccine in the next few days - Reuters

February 12, 2021 1:04 PM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

EU drug regulator EMA expects Johnson & Johnson (NYSE: JNJ) to file for approval of its COVID-19 vaccine in the next few days - Reuters



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk